MARKET

GLMD

GLMD

Galmed Pharmaceu
NASDAQ
0.5735
0.0000
0.00%
Opening 09:30 06/26 EDT
OPEN
0.5641
PREV CLOSE
0.5735
HIGH
0.5641
LOW
0.5641
VOLUME
16
TURNOVER
4
52 WEEK HIGH
2.340
52 WEEK LOW
0.4111
MARKET CAP
4.41M
P/E (TTM)
-0.2398
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 3d ago
Galmed Agrees With Acquisition Target Colospan To Increase The Cash Portion Of Purchase Price By $800K In Lieu Of Issuing $2M In Shares
Benzinga · 4d ago
Galmed announces restructured acquisition terms for Colospan
TipRanks · 4d ago
Galmed Pharmaceuticals Closes Amended All-Cash Colospan Acquisition With Earnout Structure
TipRanks · 4d ago
Galmed restructures Colospan deal terms, swaps $2 million share payment for earnout and extra cash
PUBT · 4d ago
GALMED PHARMACEUTICALS - INCREASES CASH PAYMENT BY $800K, RESTRUCTURES $2 MLN EARNOUT STARTING Q3 2027
Reuters · 4d ago
Galmed Pharmaceuticals Ltd. Announces Restructured Acquisition Terms for Colospan Ltd., Prioritizing CG-100 European Commercialization and Shareholder Value Protection and Consummation of Acquisition
PR Newswire · 4d ago
Weekly Report: what happened at GLMD last week (0615-0619)?
Weekly Report · 4d ago
More
About GLMD
Galmed Pharmaceuticals Ltd. is an Israel-based biopharmaceutical company dedicated to the development of therapeutics for the treatment of liver diseases. The Company is focused its research and development efforts on addressing unmet medical needs in the field of liver health. The Company's flagship product is Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule. Aramchol is aimed to be effective in the treatment of non-alcoholic steatohepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The Company's drug aims to be efficient treatment of NASH, a chronic liver disease characterized by fat accumulation, inflammation, and fibrosis, which can lead to cirrhosis and liver cancer if left untreated.

Webull offers Galmed Pharmaceuticals Ltd stock information, including NASDAQ: GLMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GLMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GLMD stock methods without spending real money on the virtual paper trading platform.